51 Biggest Movers From Yesterday

Gainers

  • Pyxus International Inc PYX shares climbed 26.9% to close at $17.04 on Tuesday after Imperial Capital initiated coverage on the stock with an Outperform rating and announced a $71 price target.
  • Allergan plc AGN shares gained 25.4% to close at $162.43 on Tuesday after AbbVie Inc ABBV announced plans To acquire Allergan for $188.24 per share in cash and stock.
  • Syros Pharmaceuticals, Inc. SYRS rose 16.4% to close at $7.52.
  • Xencor Inc XNCR climbed 13.9% to close at $38.56 after it was announced the company would replace HFF Inc in the S&P SmallCap 600.
  • Atossa Genetics Inc. ATOS gained 13.8% to close at $2.31.
  • SilverSun Technologies, Inc. SSNT shares climbed 13.4% to close at $2.79.
  • Pier 1 Imports, Inc. PIR gained 12.8% to close at $8.66 on Tuesday after falling 32.2% on Monday.
  • Xenetic Biosciences, Inc. XBIO rose 12.3% to close at $9.16.
  • Mesoblast Limited MESO rose 11.8% to close at $5.60.
  • Capital Senior Living Corporation CSU surged 11.7% to close at $4.86.
  • Replimune Group, Inc. REPL surged 11.7% to close at $14.31.
  • ARCA biopharma, Inc. ABIO gained 11.2% to close at $7.42.
  • Arbutus Biopharma Corporation ABUS jumped 11% to close at $2.42.
  • Rafael Holdings, Inc. RFL rose 10.6% to close at $26.54. Rafael Pharmaceuticals entered into an out-licensing agreement with Ono Pharmaceutical to accelerate clinical development and commercialization of cancer drug candidate CPI-613 in Japan and other Asian countries.
  • Dova Pharmaceuticals, Inc. DOVA gained 9.6% to close at $10.25 after the company announced European Union Marketing authorization for DOPTELET for the treatment of thrombocytopenia in patients with chronic liver disease.
  • Riot Blockchain, Inc. RIOT shares rose 8.6% to close at $3.3000 after climbing 10.55% on Monday.
  • Hemispherx Biopharma, Inc. HEB shares jumped 8.5% to close at $4.3200.
  • ArQule, Inc. ARQL rose 8.1% to close at $10.82. ArQule priced 9.25 million share offering at $9.75 per share.
  • USANA Health Sciences, Inc. USNA gained 7.6% to close at $77.82. USANA Health Sciences will replace Fidelity Southern in the S&P SmallCap 600 on Monday, July 1.
  • Biopharmx Corp BPMX shares fell 7.4% to close at $0.8200 after the company announced that its Phase 2b trial of BPX-04 for Populopustular Rosacea met both primary and secondary endpoints and was well tolerated.
  • Rubius Therapeutics, Inc. RUBY jumped 6.5% to close at $14.60.
  • Mesa Laboratories, Inc. MLAB shares rose 5.5% to close at $238.60. Mesa Laboratories will replace Axon Enterprise in the S&P SmallCap 600 on Monday, July 1.
  • Grubhub Inc. GRUB rose 5.1% to close at $75.90. Citigroup upgraded GrubHub from Neutral to Buy.
  • Acasti Pharma Inc. ACST gained 4% to close at $1.05 following a bullish Seeking Alpha blog post that mentioned potential valuation around $55 per share.

 


Losers

  • Acer Therapeutics Inc ACER shares dipped 78.6% to close at $4.12 on Tuesday after the FDA rejected its New Drug Application for EDSIVO.
  • Conatus Pharmaceuticals Inc CNAT dropped 68.5% to close at $0.2901 after reporting that top-line results from the ENCORE-LF trial of emricasan did not meet the primary endpoint and will discontinue further treatment of patients enrolled.
  • Gamida Cell Ltd GMDA fell 30.9% to close at $4.9800. Gamida Cell announced the launch of a proposed follow-on public offering of about $30 million worth of its shares.
  • Cemtrex, Inc. CETX dropped 29.6% to close at $2.3100. Cemtrex completed the development of augmented reality application for National Cultural Center in Saudi Arabia.
  • VivoPower International PLC VVPR shares declined 27.3% to close at $1.4900.
  • Immunic, Inc. IMUX fell 25.6% to close at $13.20 after rising 90.86% on Monday.
  • India Globalization Capital, Inc. IGC shares fell 18.1% to close at $1.68.
  • comScore, Inc. SCOR dropped 18% to close at $6.10.
  • Gravity Co., Ltd. GRVY dropped 17.3% to close at $45.00.
  • CEL-SCI Corporation CVM fell 17.1% to close at $7.19.
  • Basic Energy Services, Inc. BAS dipped 16.5% to close at $2.03 after Piper Jaffray downgraded the stock from Overweight to Neutral.
  • AbbVie Inc. ABBV fell 16.3% to close at $65.70 after the company announced it will acquire Allergan for $188.24 per share.
  • China Internet Nationwide Financial Services Inc. CIFS dropped 12.8% to close at $1.97.
  • Golden Bull Limited DNJR shares slipped 12.5% to close at $3.2300.
  • Aldeyra Therapeutics, Inc. ALDX dropped 12.4% to close at $6.21. Aldeyra, which focuses on therapies for immune-mediated diseases, reported its Phase 3 trial dubbed SOLACE that evaluated its reproxalap, code-named ADX-102 (a topical ophthalmic solution) in non-infectious anterior uveitis did not meet both the primary and secondary endpoints.
  • Uniti Group Inc. UNIT dropped 12.3% to close at $9.38. Uniti reported the launch of exchangeable notes offering and extension of revolving credit facility.
  • Epizyme, Inc. EPZM fell 12.1% to close at $13.29.
  • Brighthouse Financial, Inc. BHF shares fell 11.7% to close at $33.66. Credit Suisse downgraded Brighthouse Financial from Neutral to Underperform and lowered the price target from $35 to $22, while Goldman Sachs downgraded the stock from Neutral to Sell and lowered the price target from $39 to $32.
  • Amtech Systems, Inc. ASYS fell 11.6% to close at $5.10.
  • Zynex, Inc. ZYXI dropped 10.5% to close at $10.50.
  • Coda Octopus Group, Inc. CODA dipped 10.4% to close at $12.98.
  • Evofem Biosciences, Inc. EVFM tumbled 9.8% to close at $6.02.
  • Forterra, Inc. FRTA shares fell 9.4% to close at $4.1300. Forterra named Karl Watson as CEO and reaffirmed its FY19 outlook.
  • Seres Therapeutics, Inc. MCRB fell 7% to close at $2.79.
  • Minerva Neurosciences, Inc. NERV fell 6.1% to close at $5.57 after surging 40.19% on Monday.
  • The Medicines Company MDCO fell 4.5% to close at $33.76 after reporting a $150 million common stock offering.
  • Pivotal Software, Inc. PVTL fell 4.1% to close at $10.89. Bank of America downgraded Pivotal Software from Neutral to Underperform and lowered the price target from $16 to $12.
Posted In: LosersMovers From TuesdayMovers From YesterdayTop GainersYesterday's GainersNewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneral